Immuto Scientific is a biotechnology services company that provides analytical insights to pharmaceutical companies for drug discovery.
Immuto Scientific has raised $8.0M in total funding. The most recent round was Seed. The last funding was announced in September 2025.
Immuto Scientific's investors include National Institutes of Health, NVNG Investment Advisors, Great Oaks Venture Capital, Golden Angels Investors, gbeta.
Immuto Scientific is headquartered in Madison, United States.
Immuto Scientific is a biotechnology services company that provides analytical insights to pharmaceutical companies for drug discovery.
Immuto Scientific is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Immuto Scientific — Funding & Investors." VCBacked, September 18, 2025, https://www.vcbacked.co/company/immuto-scientific. Accessed September 12, 2026.
VCBacked. (2025). Immuto Scientific — Funding & Investors. Retrieved September 12, 2026, from https://www.vcbacked.co/company/immuto-scientific
{{cite web |title=Immuto Scientific — Funding & Investors |url=https://www.vcbacked.co/company/immuto-scientific |website=VCBacked |access-date=September 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated